← Back to All Filings

UnitedHealth Group CFO Receives Dividend Equivalents on RSUs

Low SignificanceSeptember 25, 2026 at 6:46:58 PM EDT

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# UnitedHealth Group Inc (UNH) - Form 4 Filing
**Insider:** Wayne S. DeVeydt (Chief Financial Officer)
**Transaction Date:** September 22, 2026
**Type:** Grant/Award (Code A - Dividend Equivalents)
**Shares:** +106.233 shares @ $0.00
**Total Value:** $0.00
**Post-Transaction Ownership:** 18,675.758 shares (Direct)
**Significance:** Low (Routine dividend equivalent accrual on RSUs)

Comprehensive Analysis

Executive Summary

On September 24, 2026, UnitedHealth Group Inc (NYSE: UNH) filed a Form 4 disclosing that Chief Financial Officer Wayne S. DeVeydt acquired 106.233 shares of common stock on September 22, 2026. The shares represent dividend equivalents paid on outstanding restricted stock units (RSUs) and carry a stated purchase price of $0.00. Following this routine transaction, DeVeydt directly owns 18,675.758 shares of UNH common stock.

Transaction Analysis

  • Transaction Nature: The transaction is classified under code 'A' (Grant, award, or other acquisition). As detailed in footnote (1), these shares are dividend equivalents credited on existing unvested RSUs. They remain subject to the same vesting and forfeiture conditions as the underlying grants.
  • Significance Level: Low. This is an automated/non-discretionary corporate compensation event rather than an open-market purchase or sale. It provides no direct signal regarding insider sentiment or forward-looking operational performance.
Topics:#UNH#UnitedHealth#InsiderTrading#SECForm4#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.